Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Dermatology Case Answer B: May

Alisa Femia, MD and Joseph F. Merola, MD  |  Issue: May 2013  |  May 14, 2013

Incorrect

 

B) Keratoderma blennorrhagicum

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Keratoderma blennorrhagicum (KB) is a component of the reactive arthritis syndrome, and occurs in 10% of patients with this syndrome. Lesions appear as hyperkeratotic yellowish plaques with pustules. The clinical appearance closely resembles palmoplantar psoriasis, with the only distinction being that lesions of KB are generally thicker and more hyperkeratotic than those of palmoplantar psoriasis. The absence of urethritis, uveitis, arthritis, or any other systemic symptom argues against a diagnosis of KB in this patient.

Back to the question.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Femia is a fellow in the dermatology–rheumatology fellowship at Brigham and Women’s Hospital in Boston. She is a diplomat of the American Board of Dermatology.


Dr. Merola is an instructor in the department of dermatology at Harvard Medical School and a fellow in the rheumatology division at Brigham and Women’s Hospital, both in Boston. He is the assistant program director for the combined medicine–dermatology training program and a diplomat of the American Board of Dermatology and the American Board of Internal Medicine.

Share: 

Filed under:Conditions

Related Articles

    Dermatology Case Answer C: May

    May 14, 2013

    C) Tumor necrosis factor (TNF)–α-induced palmoplantar pustular psoriasis

    Secukinumab Promising for Sustained Improvements in Palmoplantar & Nail Psoriasis

    February 28, 2018

    In clinical trials, secukinumab proved safe and effective as a long-term treatment for both palmoplantar and nail psoriasis…

    Dermatology Case Question: May

    May 1, 2013

    Test your diagnostic knowledge with this cutaneous eruption on the palms and soles

    Dermatology Case Answer: History of ANCA–Associated Vasculitis, Fever, Rash

    April 6, 2012

    A 66-year-old woman with a history of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis presents with two days of fever and rash.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences